id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-353939-vz2bpkyk	Ranger, Amita	Interleukin‐6 Blockade Treatment for COVID‐19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia	2020-06-01		.txt	text/plain	693	45	39	title: Interleukin‐6 Blockade Treatment for COVID‐19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia There have been published case series and reports of the successful treatment of COVID-19 induced CRS with Tocilizumab 4-6 . We describe our experience of the successful treatment of a patient with chronic myeloid leukaemia (CML) and COVID-19 associated CRS with Tocilizumab in a district general hospital setting. Despite overall improved outcomes in haematology patients 8 We describe the successful treatment of COVID-19 associated CRS with Tocilizumab in a patient with an uncontrolled haematological malignancy. Therapies such as this have the potential to change the outcome of severe COVID-19 infection and prevent ICU admission, particularly in patients believed to be unsuitable for critical care or where there is a great demand on critical care resources. Dysregulation of immune response in patients with COVID-19 in Wuhan, China	./cache/cord-353939-vz2bpkyk.txt	./txt/cord-353939-vz2bpkyk.txt